$RYTM 4 SEC Filings

Filed On	Filing
14 Sep 2026	Form 4: Meeker David P, Director Received 50,000 shares by exercise or conversion ($303K) · Sold 50,000 shares ($5.13M)
01 Sep 2026	Form 4: Smith Hunter C, Chief Financial Officer Received 57,187 shares by exercise or conversion ($1.47M) · Sold 62,774 shares ($6.62M)
18 Aug 2026	Form 4: Joshi Manher, Chief Medical Officer Granted 50,000 Stock Options (Right to Buy) · Granted 25,000 Restricted Stock Units
17 Aug 2026	Form 4: Shulman Joseph, Chief Technical Officer Received 2,024 shares by exercise or conversion ($13.8K) · Sold 5,079 shares ($608K)
17 Aug 2026	Form 4: Garfield Alastair, Chief Scientific Officer Sold 7,763 shares ($913K)
14 Aug 2026	Form 4: Lee Jennifer Kayden, EVP, Head of North America Received 56,601 shares by exercise or conversion ($997K) · Sold 75,834 shares ($8.9M)
14 Aug 2026	Form 4: Mazabraud Yann, EVP, Head of International Received 46,625 shares by exercise or conversion ($317K) · Sold 57,000 shares ($6.62M)
02 Jul 2026	Form 4: Garfield Alastair, Chief Scientific Officer Received 4,445 shares by exercise or conversion · Gave up 2,150 shares to cover exercise price or tax ($237K)
25 Jun 2026	Form 4: Tetrault Lynn A., Director Received 4,712 shares by exercise or conversion · Granted 3,691 Stock Option (right to buy) · Granted 2,324 Restricted Stock Units
25 Jun 2026	Form 4: Jean Christophe, Director Received 4,712 shares by exercise or conversion · Granted 3,691 Stock Option (right to buy) · Granted 2,324 Restricted Stock Units
25 Jun 2026	Form 4: Mcgirr David W J, Director Received 4,712 shares by exercise or conversion · Granted 3,691 Stock Option (right to buy) · Granted 2,324 Restricted Stock Units
25 Jun 2026	Form 4: Arbuckle Stuart A, Director Received 4,712 shares by exercise or conversion · Granted 3,691 Stock Option (right to buy) · Granted 2,324 Restricted Stock Units
25 Jun 2026	Form 4: Good Jennifer L, Director Received 4,712 shares by exercise or conversion · Granted 3,691 Stock Option (right to buy) · Granted 2,324 Restricted Stock Units
24 Jun 2026	Form 4: Tetrault Lynn A., Director Received 37,000 shares by exercise or conversion ($1.05M) · Sold 37,000 shares ($3.71M)
20 May 2026	Form 4: Smith Hunter C, Chief Financial Officer Received 3,000 shares by exercise or conversion ($53.6K)
19 May 2026	Form 4: German Christopher Paul, Corporate Controller & CAO Received 4,442 shares by exercise or conversion ($187K) · Sold 4,643 shares ($428K)
03 Apr 2026	Form 4: Popovits Kimberly J, Director Granted 6,808 Restricted Stock Units · Granted 10,257 Stock Options (Right to Buy)
03 Apr 2026	Form 4: Mazabraud Yann, EVP, Head of International Received 12,875 shares by exercise or conversion
16 Mar 2026	Form 4: Mathers Edward T, Director Acquired 4,199 shares (Other Transaction)
06 Mar 2026	Form 4: German Christopher Paul, Corporate Controller & CAO Received 1,500 shares by exercise or conversion ($27K) · Sold 5,614 shares ($503K)

Comments